Site icon OncologyTube

Outcomes of Keynote 189 in metastatic NSCLC

Edgardo S. Santos, MD, FACP, talks about whether Keynote 189 in metastatic non-small cell lung cancer (NSCLC) has impacted his view of PDL-1 expression and patient selection

Exit mobile version